Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Intranasal administration achieved median Tmax of 0.50 hours with terminal half-life ranging from 1.85 to 2.09 hours in male studies
No rounding errors
Ida S, Kaneko R, Imataka K, Okubo K, Shirakura Y, Azuma K, et al
Conversely, abnormal blood glucose levels have been shown to elevate cancer risk and decrease survival rates in cancer patients [12, 50]
00967-0/asset/fbcb1dac-2f21-4c7c-b986-2511be29cd39/main.assets/gr2.jpg)
It is an investigational drug currently in Phase 3 clinical trials
Think about the variety of treatments, noting whether both oral and injectable options are available
US$ 20.39
US$ 26.88
US$ 21.81
